EMA — authorised 16 November 2017
- Marketing authorisation holder: Tesaro UK Limited
- Status: approved
EMA authorised Zejula on 16 November 2017
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 16 November 2017.
Tesaro UK Limited holds the EU marketing authorisation.